iRay Technology Hits Day Low of CNY 105.01 Amid Price Pressure

iRay Technology Co., Ltd. experienced a significant decline today, with its stock price dropping by 8.49% to reach an intraday low of CNY 105.01. This performance stands in contrast to the broader market, as the China Shanghai Composite index only fell by 1.0% on the same day. Over the past week, iRay Technology has seen a more pronounced downturn, with a total decline of 11.77%. The company's performance over the last month also reflects a negative trend, with a decrease of 9.92%. However, it is noteworthy that the stock has shown a remarkable annual return of 64.65%, significantly outperforming the China Shanghai Composite's 13.86% gain. Despite this strong yearly performance, iRay Technology has faced challenges, including negative results for the last three consecutive quarters. The company's financial metrics indicate a high valuation, with a Price to Book ratio of 4.69 and a Return on Equity of 9.68%. Additionally, raw material costs have surged by 102.8% year-over-year, impacting profitability. As a large-cap player in the Pharmaceuticals & Biotechnology sector, iRay Technology's current market cap stands at CNY 34,948 million.